Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11773095 Organic compounds
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Date Filed
July 19, 2022
Date of Patent
October 3, 2023
Patent Application Number
17813473
Patent Citations
US Patent 9168258 Methods and compositions for sleep disorders and other disorders
US Patent 10117867 Methods and compositions for sleep disorders and other disorders
US Patent 10245260 Organic compounds
US Patent 10322134 Methods
US Patent 10472359 Pharmaceutical compositions comprising 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl) butan-1-one for inhibiting serotonin reuptake transporter activity
US Patent 10533015 Opioid receptor antagonist prodrugs
US Patent 10597394 Organic compounds
US Patent 10597395 Preparation of certain substituted 1-(4-fluorophenyl)-4-(2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-YL)butan-1-ones and pharmaceutically acceptable salts thereof
US Patent 10682354 Compositions and methods
US Patent 10688097 Organic compounds
•••
Patent Inventor Names
Sharon Mates
Robert Davis
Hailin Zheng
Kimberly Vanover
Peng Li
Gretchen Snyder
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
11773095
Patent Primary Examiner
Taylor V Oh
CPC Code
A61K 31/4985
A61K 31/5383
A61K 31/55
A61K 9/0019
A61K 31/137
A61K 2300/00
A61P 1/00
A61K 31/485
A61P 25/36
A61P 29/00
•••
Find more entities like US Patent 11773095 Organic compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE